Question 1

What is the catalog number for TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8, CD30, D1S166E, KI-1)?

Accepted Answer

The catalog number for TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8, CD30, D1S166E, KI-1) is 252838.

Question 2

What sizes are available for TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8, CD30, D1S166E, KI-1)?

Accepted Answer

TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8, CD30, D1S166E, KI-1) is available in the following size(s): 100 µg.

Question 3

Is TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8, CD30, D1S166E, KI-1) in stock?

Accepted Answer

TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8, CD30, D1S166E, KI-1) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 5

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Question 6

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8, CD30, D1S166E, KI-1)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

E-Cadherin (CDH1) / CD324 (Intercellular Junction Marker) (rCDH1/1525), CF488A conjugate, 0.1mg/mL

PAX2 (Renal Cell & Ovarian Carcinoma Marker) (PAX2/1104), CF405S conjugate, 0.1mg/mL

CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/3126R), CF740 conjugate, 0.1mg/mL

Bcl-6 (Follicular Lymphoma Marker) (rBCL6/1527), CF405S conjugate, 0.1mg/mL

S100B (4C4.9 + S100B/1012), 0.2mg/mL

CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/2145), CF640R conjugate, 0.1mg/mL